We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$29.4M
(-9.8%)
Cap. Flow
-$45.9M
Cap. Flow
% of AUM
-17.01%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
110
New
22
Increased
25
Reduced
44
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$10.3M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.67M |
| 3 |
AKRX
Akorn Inc
AKRX
|
+$3.38M |
| 4 |
SHPG
Shire pic
SHPG
|
+$3.35M |
| 5 |
HCA Healthcare
HCA
|
+$3.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$8.81M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$8.25M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$5.07M |
| 4 |
Encompass Health
EHC
|
+$5.04M |
| 5 |
Becton Dickinson
BDX
|
+$4.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.33% |
| 2 | Financials | 3.58% |
| 3 | Industrials | 1.13% |
| 4 | Energy | 0.58% |
| 5 | Technology | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $18.5M | 6.87% |
95,546
+17,150
| +22% | +$3.35M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $14M | 5.19% |
60,800
-12,300
| -17% | -$3.01M |
|
3
Abbott
ABT
$183B
| $10.4M | 3.87% |
246,608
-60,894
| -20% | -$2.61M |
|
|
AMSG
4
DELISTED
Amsurg Corp
AMSG
| $9.89M | 3.67% |
+147,500
| New | +$10.3M |
|
|
5
Encompass Health
EHC
$11B
| $9.85M | 3.65% |
305,079
-155,628
| -34% | -$5.04M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $9.66M | 3.58% |
83,665
-10,450
| -11% | -$1.22M |
|
|
STJ
7
DELISTED
St Jude Medical
STJ
| $8.7M | 3.22% |
109,048
-12,234
| -10% | -$988K |
|
|
HOLX
8
DELISTED
Hologic
HOLX
| $8.64M | 3.2% |
222,558
+54,350
| +32% | +$2.05M |
|
|
MNK
9
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $8.42M | 3.12% |
120,674
-114,055
| -49% | -$8.25M |
|
10
Stryker
SYK
$125B
| $8.34M | 3.09% |
71,665
+27,200
| +61% | +$3.17M |
|
11
UnitedHealth
UNH
$376B
| $8.27M | 3.06% |
59,056
+8,450
| +17% | +$1.18M |
|
|
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
| $7.78M | 2.88% |
96,464
+18,150
| +23% | +$1.48M |
|
13
McKesson
MCK
$100B
| $7.72M | 2.86% |
46,272
-24,366
| -34% | -$4.54M |
|
14
Boston Scientific
BSX
$69.5B
| $6.15M | 2.28% |
258,298
-108,700
| -30% | -$2.59M |
|
|
15
Teva Pharmaceuticals
TEVA
$40.8B
| $6.14M | 2.28% |
133,433
-97,100
| -42% | -$5.07M |
|
16
Centene
CNC
$30.7B
| $6.07M | 2.25% |
181,376
-22,700
| -11% | -$789K |
|
17
Cencora
COR
$60.6B
| $5.65M | 2.09% |
69,965
+21,365
| +44% | +$1.83M |
|
18
Biogen
BIIB
$30B
| $5.46M | 2.02% |
17,432
-3,100
| -15% | -$918K |
|
|
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
| $5.42M | 2.01% |
76,827
+49,100
| +177% | +$3.67M |
|
20
DaVita
DVA
$15.4B
| $5.24M | 1.94% |
79,339
+25,450
| +47% | +$1.79M |
|
|
WMGI
21
DELISTED
Wright Medical Group Inc
WMGI
| $4.65M | 1.72% |
189,578
-382,450
| -67% | -$8.81M |
|
|
22
HCA Healthcare
HCA
$87.2B
| $4.34M | 1.61% |
57,400
+43,489
| +313% | +$3.33M |
|
23
Zimmer Biomet
ZBH
$18.2B
| $4.19M | 1.55% |
33,180
+1,039
| +3% | +$128K |
|
24
Labcorp
LH
$25B
| $4.02M | 1.49% |
34,003
-21,185
| -38% | -$2.5M |
|
25
Cigna
CI
$73.7B
| $3.64M | 1.35% |
27,950
+23,861
| +584% | +$3.12M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Endurant Capital Management held 110 positions worth $270M, down 9.8% from $299M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Endurant Capital Management withdrew a net $45.9M in Q3 2016, closing 14 positions and reducing 44 holdings. Its most notable exit was Standard BioTools, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.
Against the trend, Endurant Capital Management opened a new position in Amsurg Corp worth $9.89M.
- Endurant Capital Management's largest Q3 2016 buy was Amsurg Corp: 147,500 shares worth $9.89M.
- Endurant Capital Management added most to Express Scripts Holding Company in Q3 2016, an estimated $3.67M increase.
- Endurant Capital Management's biggest Q3 2016 reduction was Wright Medical Group Inc, cutting an estimated $8.81M.
- Endurant Capital Management fully exited Standard BioTools in Q3 2016, selling an estimated $2.32M.
- Endurant Capital Management's ten largest holdings make up 39% of its $270M portfolio in Q3 2016.
- Endurant Capital Management opened 22 new positions and closed 14 in Q3 2016.
- Endurant Capital Management's portfolio value fell 9.8% quarter-over-quarter to $270M.
Based on Endurant Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.